Proposed the "stem cell" in 1908 Developed the hypothesis about the existence of "polublasts" in 19241908-1924
Alexander Yakovlevich Friedenstein Discovers Mesenchymal Stem cells1969
Dr. Anatoly Konoplyannikov becomes the Head of Cell and Experimental Raidology Therapy Department the MRRc in obnisk. Begins BM-Msc Human clinical Trials:
1200+ Clinical Trials at MRRC
2500+ Clinical Trials Internationally
Awarded 20+ medical patents
CEO Alexei Gladkov establishes AV-Cells in Singapore in 2011.
He begins to adapt BM-MSC technology from the MRRC for SE-Asia market [November]
Company obtains special extended flight delivery technology [October 2012]
Kintaro Cells Power is founded in Japan in 2014.
200+ new successful treatments preformed
Cells Production lab moved to Ginza, Tokyo
Official registration Cells Power office
in Vietnam [March 10th]
in Malaysia [June 1st]
in Thailand [July 1st]
International Brand Launch event of Kintaro Cells [October 1st]
Cells Production lab moved to Ginza, Tokyo [November 1st]
The 1st Vietnamese Consulting Center of Cells Power Japan was opened on in Hanoi [November 20th]
Continue B2B sales and medical tourism to continue standard cash flow
Branch into Immune Therapy market through collaboration with Japanese oncological cancer treatment centers and laboratories
Develop our own Immune cells therapy production "Kintaro Immune cells" with full government permission
Strengthen network of clinics,universities, and sales agents
Lab expansion: Using the same technology & methods from our Tokyo lab, we set up local production labs across the region
Taking permisson for clinical trials in other countries across SE-Asia
THE DOORS TO JAPAN HAVE OPENED
for select disease treatments. Boost of inbound medical tourism to Japan Domestic sales
BRAND AWARENESS BY SALES
"Kintaro" brand of BM-MSC, Immune Cells, and Enriched Medium is common term is SE-Asia and Japan. Brand power increases by collecting more cellular products.
Create new offices, labs, and networks of clinics throughout China, the Middle East, and other locations
Upgrade office and laboratory to larger location to meet rising demand.
Control a market of +100 clinics/hospitals who use our product within Japan